openPR Logo
Press release

Allergy Treatment Market - Innovative Developments by 2025 | GlaxoSmithKline, Sanofi, Merck, Johnson & Johnson

01-29-2019 04:14 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Allergy Treatment Market - Innovative Developments by 2025 |

An allergy is defined as a hypersensitive reaction to various foreign substances by the immune system. The substances that trigger an allergy are called allergens. Examples include pollens, dust mite, molds, pet dander, certain foods, and others. Patients prone to allergies are said to be allergic or atopic.

The allergy treatment market is anticipated to grow at a fast pace owing to the rise in focus on new treatment developments for allergy specific drugs, the advent of immunotherapy, an increase in the prevalence of allergies across the globe.

Get Sample Copy of Report @ https://www.alliedmarketresearch.com/request-sample/3541?utm_source=openpr&utm_medium=ss

The global allergy treatment market was valued at $24,653 million in 2017 and is projected to reach $40,360 million by 2025, growing at a CAGR of 6.3% from 2018 to 2025.

Based on the type, the rhinitis segment generated the highest revenue in 2017 and is expected to maintain this dominance throughout the forecast period. This is attributed to the increased prevalence of allergic rhinitis across the globe.

For instance, according to the European Academy of Allergy and Clinical Immunology (EAACI), around 400 million patients suffer from rhinitis. However, the food allergy segment is expected to register the highest growth rate during the forecast period.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3541?utm_source=openpr&utm_medium=ss

Key Benefits:

•The study provides an in-depth analysis of the global allergy treatment market with the current trends and future estimations to elucidate the imminent investment pockets.

•A comprehensive analysis of the factors that drive and restrict market growth is provided.

•A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

•An extensive analysis of the key segments of the industry helps to understand the trends in the global allergy treatment market.

•Key players and their strategies are provided to understand the competitive outlook of the industry.

Leading Companies:

•GlaxoSmithKline
•ALK-Abell A/S
•Sallergenes Greer
•Allergy Therapeutics
•Sanofi SA
•Johnson & Johnson

Browse More Details of Report @ https://www.alliedmarketresearch.com/allergy-treatment-market?utm_source=openpr&utm_medium=ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergy Treatment Market - Innovative Developments by 2025 | GlaxoSmithKline, Sanofi, Merck, Johnson & Johnson here

News-ID: 1542990 • Views:

More Releases from Allied Market Research

Neobanking Market Size to Generate $3.3 Trillion by 2032 at 9.0% CAGR | Increase …
Allied Market Research published a report, titled, "Neobanking Market by Account Type (Business Account and Savings Account), Service Type (Mobile Banking, Payments & Money Transfer, Checking/Saving Accounts, Loans, and Others), and Application (Enterprise, Personal): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global Neobanking Market was valued at $68.95 billion in 2022 and is estimated to reach $3,251.95 billion by 2032, exhibiting a CAGR of 47.3%
Singapore Remittance Market Outlook 2023-2032: Size, Share & Trends
Allied Market Research has published a report titled, "Singapore Remittance Market by Type (Inward Remittance and Outward Remittance), Channel (Banks, Money Transfer Operators, and Others), Application (Consumption, Savings, and Investment), Mode (B2B, B2C, C2B, and C2C), and End User (Migrant Labor Workforce, Low-Income Households, Small Businesses, and Others): Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the Singapore remittance market was valued at $528.04 million in 2022 and is
Premium Finance Market to Hit $139.7 Billion by 2032, Driven by Growing Insuranc …
According to a new report published by Allied Market Research, titled, "Premium Finance Market by Type (Life Insurance and Non-life Insurance), by Interest Rate (Fixed Interest Rate and Floating Interest Rate), and by Provider (Banks, NBFCs, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032," the premium finance market was valued at $47.8 billion in 2022 and is projected to reach $139.7 billion by 2032, registering a CAGR of 11.5%
Insurance Claims Services Market to Hit $638.3 Billion by 2032, Growing at 12.8% …
According to a new report published by Allied Market Research, titled, "Insurance Claims Services Market," the market was valued at $193.8 billion in 2022 and is projected to reach $638.3 billion by 2032, growing at a CAGR of 12.8% from 2023 to 2032. Get a Sample Copy of this Report : https://www.alliedmarketresearch.com/request-sample/A09995 The increasing integration of advanced technologies such as artificial intelligence (AI), data analytics, and automation has revolutionized the claims process

All 5 Releases


More Releases for Allergy

Allergy Shots Market | ALK Abello, Aimmune Therapeutics, Allergy Therapeutics, A …
The global allergy shots market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the allergy shots market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Allergy Shots Market: Rising Demand and Advancements in Allergy Treatment
Market Overview: The Allergy Shots market refers to the production, distribution, and utilization of immunotherapy treatments known as allergy shots or allergen immunotherapy. Allergy shots are a form of treatment for allergies, particularly for allergic rhinitis (hay fever), allergic asthma, and insect sting allergies. They involve the administration of gradually increasing doses of allergens, such as pollen, dust mites, pet dander, or insect venom, to desensitize the immune system and
Allergy Treatment Market Increasing Demand By Allergy Type: Eye Allergy, Rhiniti …
Acumen Research and Consulting has announced the addition of the "Allergy Treatment Market” report to their offering. The Allergy Treatment Market Report 2018 is an in depth study analyzing the current state of the Allergy Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Allergy Treatment Market provides analysis of China market covering the industry trends, recent
Allergy Immunotherapy Market to Witness Huge Growth by Key Players: Allergy Ther …
According to a recent research study "Allergy Immunotherapy Market, by immunotherapy Type (SCIT, SLIT), By Type of Allergy (Asthma, Food Allergy, Allergic Rhinitis and Others) opportunities and forecast 2020-2026" published by Data Library Research, the Allergy Immunotherapy Market Studies many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key
Allergy Treatment Market Report 2018: Segmentation by Allergy Type (Food Allergy …
Global Allergy Treatment market research report provides company profile for Meda Pharmaceuticals Inc., Allergy Therapeutics, Sunovion Pharmaceuticals Inc., Allergon AB, Allergan, HAL Allergy Group, Teva Pharmaceutical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Allergy Treatment Global Market 2018: Key Players – ALK, Stallergenes Greer, A …
Allergy Treatment Industry Description Wiseguyreports.Com Adds “Allergy Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global Allergy Treatment market, analyzes and researches the Allergy Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like  ALK  Stallergenes Greer  Allergy Therapeutics  HAL Allergy Group  Circassia  GlaxoSmithKline plc  Sunovion Pharmaceuticals  Teva Pharmaceutical Industries  Allergan plc  Allergon